Market news
TypeAll
SortNewest
Assets
MRNY
The Melanoma Win Is Real, The Price Isn't - Moderna And MRNY Both Sell (NASDAQ:MRNA)
Moderna (MRNA) and MRNY are rated Sell on stretched valuation after melanoma Phase 3 news.
This is the newest page. Registered accounts read further back.